Vladimir Vexler - Mar 31, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Stock symbol
CHRS
Transactions as of
Mar 31, 2023
Transactions value $
-$111,342
Form type
4
Date filed
4/4/2023, 09:02 PM
Previous filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$111K -16.3K -12.27% $6.84 116K Mar 31, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Vladimir Vexler is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.
F2 Includes 1,316 shares acquired on May 13, 2022, pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan.